Home   >  
Protease/Metabolic Enzyme
  >  
Mitochondrial Metabolism

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Mitochondrial Metabolism

Chemical Structure Cat. No. Product Name CAS No.
DX3-213B Chemical Structure
BCP46463 DX3-213B 2749555-66-4
DX3-213B is a highly potent, orally active oxidative phosphorylation (OXPHOS) complex I inhibitor. DX3-213B impairs ATP generation, and blocks MIA PaCa-2 cell growth.
Mito-apocynin (C11) Chemical Structure
BCP46038 Mito-apocynin (C11) 1254044-38-6
Mito-apocynin (C11), an orally active mitochondria-targeted triphenylphosphonium (TPP)-based compound, is synthesized by conjugating the Apocynin moiety with a TPP+ cation.
L-Histidine Chemical Structure
BCP45568 L-Histidine 71-00-1
L-Histidine is an essential amino acid for infants. L-Histidine is an inhibitor of mitochondrial glutamine transport.
NL-1 Chemical Structure
BCP45211 NL-1 188532-26-5
NL-1 is a mitoNEET inhibitor with antileukemic effect.
MitoTEMPO Chemical Structure
BCP43473 MitoTEMPO 1334850-99-5
Mito-TEMPO is a mitochondria-targeted superoxide dismutase mimetic with superoxide and alkyl radical scavenging properties.
Mito-LND Chemical Structure
BCP42814 Mito-LND 2361564-49-8
Mito-LND is an orally active and mitochondria-targeted inhibitor of oxidative phosphorylation (OXPHOS).
CCI-006 Chemical Structure
BCP40217 CCI-006 292053-42-0
CCI-006 is a selective inhibitor and chemosensitizer of MLL-rearranged leukemia cells, by inhibits mitochondrial respiration resulting in insurmountable mitochondrial depolarization and a pro-apoptotic unfolded protein response (UPR) in a subset of MLL-r leukemia cells.
CTPI-2 Chemical Structure
BCP37418 CTPI-2 68003-38-3
CTPI-2 is a specific SLC25A1 inhibitor.
Mitochonic Acid 5 Chemical Structure
BCP34060 Mitochonic Acid 5 1354707-41-7
Mitochonic acid 5 binds mitochondria and ameliorates renal tubular and cardiac myocyte damage. Mitochonic acid 5 modulates mitochondrial ATP synthesis.
MSDC 0602 Chemical Structure
BCP33206 MSDC 0602 1133819-87-0
MSDC 0602 is an insulin sensitizer potentially for the treatment of diabetes (metabolic modulator).
12下一页共 18 条记录 1 / 2 页 
0086-13720134139